Skip to main content
Clinical Trials/NCT01949389
NCT01949389
Completed
Not Applicable

Piloting an Internet-based Therapy for Insomnia in a Population of Veterans With Substance Use Disorders

VA Connecticut Healthcare System1 site in 1 country51 target enrollmentOctober 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Insomnia
Sponsor
VA Connecticut Healthcare System
Enrollment
51
Locations
1
Primary Endpoint
Insomnia Severity Index (Total), Change From Baseline to Follow-up
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The purposes of this study is to examine the feasibility of implementing an internet-based treatment for insomnia among veterans with substance use disorders, some with co-morbid serious mental illness, and to develop potential methods to support and encourage veterans while they self-administer this treatment. Our hypotheses are that the implementation of an internet-based therapy will be feasible and that a method of support can be devised, and tested in the future.

Registry
clinicaltrials.gov
Start Date
October 2012
End Date
August 2015
Last Updated
10 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
VA Connecticut Healthcare System
Responsible Party
Principal Investigator
Principal Investigator

Robert Rosenheck

Senior Health Serivces Investigator

VA Connecticut Healthcare System

Eligibility Criteria

Inclusion Criteria

  • Inability to sleep within 30 minutes of going to bed or awakening during the night for 30 minutes for greater than or equal to 3 days per week
  • Above Criteria occurring every week for greater than or equal to 3 months
  • At least one symptom of daytime impairment: (reduced motivation, sleepiness, fatigue, lack of concentration, performance at home, work, social life, relationships impaired)
  • Able to provide valid consent
  • Willing to participate in an internet-based cognitive behavioral therapy for insomnia
  • English speaking

Exclusion Criteria

  • Self-reported or provider diagnosed sleep apnea or related nighttime respiratory problem, restless legs syndrome or related nighttime movement disorder
  • Acute psychiatric decompensation requiring inpatient admission or emergency department services within the last month (suicidality, homicidally, mania, psychotic decompensation)
  • Current treatment or treatment within the last month for opiate addiction with methadone maintenance or buprenorphine.
  • Has a conservator E. Shift work interfering with the establishment of regular sleep patterns F. Previous or ongoing cognitive behavioral therapy for insomnia

Outcomes

Primary Outcomes

Insomnia Severity Index (Total), Change From Baseline to Follow-up

Time Frame: pre-intervention, intervention completion (expected average of 7 weeks)

Insomnia Severity Index (Total) following completion of the intervention (expected average of 7 weeks) The Insomnia Severity Index is a self-report seven-item measure that targets the subjective symptoms and functional consequences of insomnia as well as the degree of concerns or distress caused by those difficulties, and corresponds to the diagnostic criteria of insomnia. Scores range from 0-28, higher scores indicate more severe insomnia, and scores ≥15 suggest moderate to severe insomnia.

Completion of All 7 Modules of the Intervention

Time Frame: on average 7 weeks

Participants will be followed for the duration of the intervention (7 individual modules, completed weekly, for an expected average of 7 weeks). Outcome measure will be characterized as the number completing all 7 modules of the program (dichotomous variable). The intervention is a 7-week, self-administered course accessed via the Internet that includes instruction on psycho-education, stimulus control, relaxation training, sleep restriction, medication tapering, cognitive distortions, and mindfulness integrated into each module. Homework is assigned after each module. Participants are instructed to complete the sleep diary included in the program daily while participating in the program.

Study Sites (1)

Loading locations...

Similar Trials